- About FSPH
- Current Students
- Prospective Students
- Alumni Affairs
- Give to the School
|Departments||Type of Faculty|
Sexually Transmitted Diseases, HIV/AIDS, Cryptococcus, Digital Technology, Global Health, Maternal-Child Health
Dr. Klausner is a Professor of Medicine in the Division of Infectious Diseases and the Program in Global Health. Dr. Klausner earned his Medical Degree from Cornell University Medical College with Honors in Research. He completed his Residency in Internal Medicine at the New York University—Bellevue Hospital Center. Dr. Klausner earned his Master’s in Public Health with a focus on International Health and Epidemiology at the Harvard School of Public Health. After that training, Dr. Klausner was an Epidemic Intelligence Service Officer at the Centers for Disease Prevention and Control. Dr. Klausner completed his Fellowship in Infectious Diseases at the University of Washington, Seattle, under the mentorship of Prof. King Holmes.
From 1998-2009 Dr. Klausner was a Deputy Health Officer, Director of STD Prevention and Control Services at the San Francisco Department of Public Health, member of the UCSF School of Medicine faculty in the Divisions of AIDS and Infectious Diseases and Attending Physician at San Francisco General Hospital. While in San Francisco Dr. Klausner helped identify key factors associated with the increase d spread of HIV and STDs and implemented multiple novel public health prevention programs. He helped create the St. James Infirmary, the first occupational health and safety clinic for sex workers and Magnet, a community-based peer-run sexual health clinic for gay men. From 2009-2011 Dr. Klausner was Branch Chief for HIV and TB at the Centers for Disease Control in Pretoria, South Africa, helping lead the South African PEPFAR program for care and treatment.
Dr. Klausner’s research interests are in applied epidemiology and the prevention and control of infectious disease s of public health importance like HIV, STDs, TB and cryptococcus. Dr. Klausner has a particular interest in the use of technology—information, digital, and laboratory—to facilitate access to treatment for disadvantaged populations. Dr. Klausner has been funded by the NIH, CDC, private pharmaceutical and test manufacturers to study the benefits of new ways to find and treat infectious diseases. Dr. Klausner has been a leading advocate in the use of medical male circumcision for HIV and STD prevention. Dr. Klausner is a frequent advisor to the CDC, NIH and WHO and a popular public speaker. Dr. Klausner is a highly sought after mentor who has trained dozens of fellows, residents and students of medicine and public health.
Please check with the faculty member or their office about availability to serve during current academic period.
Larson E, O'Bra H, Brown J, Mbengashe T, Klausner JD. Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009. BMC Public Health. 2012 Mar 9;12:173. PubMed PMID: 22404862; PubMed Central PMCID: PMC3323417.
Klausner JD, Morris BJ. Benefits of male circumcision. JAMA. 2012 Feb 1;307(5):455-6; author reply 457. PubMed PMID: 22298671.
Freeman AH, Bernstein KT, Kohn RP, Philip S, Rauch LM, Klausner JD. Evaluation of self-collected versus clinician-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae pharyngeal infection among men who have sex with men. Sex Transm Dis. 2011 Nov;38(11):1036-9. PubMed PMID: 21992980.
Madhivanan P, Krupp K, Kulkarni V, Kulkarni S, Klausner JD. Acceptability of male circumcision for HIV prevention among high-risk men in Pune, India. Sex Transm Dis. 2011 Jun;38(6):571. PubMed PMID: 21836398.
Klausner JD, Serenata C, O'Bra H, Mattson CL, Brown JW, Wilson M, Mbengashe T, Goldman TM. Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009. J Acquir Immune Defic Syndr. 2011 Mar;56(3):292-5. PubMed PMID: 21317587.
Averbach S, Wendt JM, Levine DK, Philip SS, Klausner JD. Increasing access to emergency contraception through online prescription requests. J Reprod Med. 2010 Mar-Apr;55(3-4):157-60. PubMed PMID: 20506679.
Balamane M, Winters MA, Dalai SC, Freeman AH, Traves MW, Israelski DM, Katzenstein DA, Klausner JD. Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance. Open Virol J. 2010;4:88-93. Epub 2010 May 28. PubMed PMID: 21673840; PubMed Central PMCID: PMC3111737.
Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 2010 Apr ;53(4):537-43. PubMed PMID: 19935075.
Leon SR, Konda KA, Bernstein KT, Pajuelo JB, Rosasco AM, Caceres CF, Coates TJ, Klausner JD. Trichomonas vaginalis infection and associated risk factors in a socially-marginalized female population in coastal Peru. Infect Dis Obstet Gynecol. 2009;2009:752437. Epub 2009 Jun 29. PubMed PMID: 19584943; PubMed Central PMCID: PMC2704012.
Pandori M, Barry PM, Wu A, Ren A, Whittington WL, Liska S, Klausner JD. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother. 2009 Sep;53(9):4032-4. Epub 2009 Jun 22. PubMed PMID: 19546370; PubMed Central PMCID: PMC2737862.
Pandori MW, Hackett J Jr, Louie B, Vallari A, Dowling T, Liska S, Klausner JD. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol. 2009 Aug;47(8):2639-42. Epub 2009 Jun 17. PubMed PMID: 19535523; PubMed Central PMCID:PMC2725691.
Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009 Mar;10(4):555-77. Review. PubMed PMID: 19284360; PubMed Central PMCID: PMC2657229.
Levine D, Woodruff AJ, Mocello AR, Lebrija J, Klausner JD. inSPOT: the first online STD partner notification system using electronic postcards. PLoS Med. 2008 Oct 21;5(10):e213. PubMed PMID: 18942887; PubMed Central PMCID: PMC2570420.
Philip SS, Ahrens K, Shayevich C, de la Roca R, Williams M, Wilson D, Bernstein K, Klausner JD. Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection. Clin Infect Dis. 2008 Nov 15;47(10):e79-82. PubMed PMID: 18840082.
Warner L, Klausner JD, Rietmeijer CA, Malotte CK, O'Donnell L, Margolis AD, Greenwood GL, Richardson D, Vrungos S, O'Donnell CR, Borkowf CB; Safe in the City Study Group. Effect of a brief video intervention on incident infection among patients attending sexually transmitted disease clinics. PLoS Med. 2008 Jun 24;5(6):e135. PubMed PMID: 18578564; PubMed Central PMCID: PMC2504047.
Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J. Public health. Reassessing HIV prevention. Science. 2008 May 9;320(5877):749-50. PubMed PMID: 18467575.
Zetola NM, Klausner JD, Haller B, Nassos P, Katz MH. Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA. 2007 Mar 14;297(10):1061-2. PubMed PMID: 17356026.
Klausner JD, Kohn RP, Kent CK. Azithromycin versus penicillin for early syphilis. N Engl J Med. 2006 Jan 12;354(2):203-5; author reply 203-5. PubMed PMID: 16411292.
Swearingen SG, Klausner JD. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med. 2005 Jun;118(6):571-7. Review. PubMed PMID: 15922685.
Lukehart SA, Godornes C, Molini BJ, Sonnett P, Hopkins S, Mulcahy F, Engelman J, Mitchell SJ, Rompalo AM, Marra CM, Klausner JD. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med. 2004 Jul 8;351(2):154-8. PubMed PMID: 15247355.